K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 500.00 | -3.30K |
| Total Other Revenue | -500.00 | -500.00 | -500.00 | -500.00 | -3.80K |
| Total Revenue | -500.00 | -500.00 | -500.00 | 0.00 | -3.30K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -500.00 | -500.00 | -500.00 | -500.00 | -3.80K |
| SG&A Expenses | 372.40K | 365.90K | 322.30K | 168.20K | 168.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 918.30K | 885.80K | 736.80K | 542.90K | 710.90K |
| Total Operating Expenses | 1.29M | 1.25M | 1.06M | 711.20K | 879.20K |
| Operating Income | -1.29M | -1.25M | -1.06M | -711.70K | -883.00K |
| Income Before Tax | 1.13M | 810.10K | 132.10K | 427.00K | -85.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.13 | 0.81 | 0.13 | 0.43 | -0.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.13M | 810.10K | 132.10K | 427.00K | -85.90K |
| EBIT | -1.29M | -1.25M | -1.06M | -711.70K | -883.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.09 | 0.07 | 0.05 | 0.07 | -0.01 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.08 | -0.07 | -0.08 |
| EPS Diluted | 0.03 | 0.02 | 0.00 | 0.02 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.02 | -0.06 |
| Average Basic Shares Outstanding | 46.85M | 42.09M | 34.66M | 27.22M | 26.04M |
| Average Diluted Shares Outstanding | 100.08M | 95.84M | 86.49M | 79.06M | 48.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
